Clinical Success Demonstrated in Treatment of Complicated Genitourinary Gram Negative Infections in a Physician Office Infusion Center (POIC)

Andrew H. Krinsky, MD -Infectious Disease Associates, Sarasota, FL
Jorge R. Bernett, MD, – Infectious Disease Doctors Medical Group, Walnut Creek, CA
Michael P. Dailey, MD – Infectious Disease Services of GA, Roswell, GA
Richard C. Prokesch, MD, FACP, FIDSA, – Infectious Disease Associates, PC, Riverdale, GA
Lucinda J. Van Anglen, PharmD – Healix Infusion Therapy, Inc., Sugar Land, TX

View Poster

View All

Phase II and Phase III Studies

Healix regularly and actively supports Phase II and Phase III clinical trials in each of our specialty areas, including active studies in therapies for COVID-19, Multiple Sclerosis and Intestinal Bowel Disease.

For information on partnering with Healix on a study, please contact us.